Navigation Links
Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
Date:12/7/2007

s.

"While the primary focus of our company remains the development of products for the treatment and supportive care of cancer patients, we are excited by these promising results in an animal model," added Stephen R. Seiler, Access' President and CEO. "In addition to providing a potential oral delivery option for insulin which would be attractive to a large number of pharmaceutical companies and which we would develop in partnership with a collaborator, we believe that our Cobalamin technology has applicability to a variety of cancer products, such as LHRH which are part of our developing cancer and supportive care franchise."

About Access:

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery. Access has announced the execution of a definitive merger agreement to acquire Somanta. The acquisition of Somanta has not yet closed and the closing is subject to numerous closing conditions. For additional information on Access Pharmaceuticals, please visit our website at http://www.accesspharma.com .

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: early results from our clinical trial, Cobalamin's activity in pre-clinical models, Cobalamin's potential to enable and improve oral bioavailability of active drugs, our plans to develop Cobalamin in collaboration with a partner, Cobalam
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...critical enzyme,s regulation may hold key to under... , , MEMPHIS, Tenn., Nov. 19 /PRNewswire-US...search Hospital have gained new insights into regu...ed calpains. , , As the cell,s molecular o...rocesses, including the movement of cells in tissu...
(Date:11/18/2008)... NeuroDiscovery Ltd (ASX:,NDL), a specialty neuro...any,and Sosei Group Corporation ("Sosei"; TSE Mo...armaceutical company, today announce that NeuroSol... efficacy data for NSL-043/SD118.,This investigat...pain and has,successfully completed Phase I clini...
(Date:11/18/2008)...luenza survey underscores that mothers need to get...Gold Medalist Kristi Yamaguchi joins initiative ,...e 78 percent of mothers in the United States consi...ening disease that can strike anyone, only half sa...this season, according to a new survey from the Am...
(Date:11/13/2008)... Risk of Heart Attacks, Deaths, RESTON, Va., Nov....ase,is the leading cause of death among Americans,...s of dollars and causing untold suffering. Now,the... even among those who,weren,t thought to be at ris... could cut their risk of a,heart attack, stroke an...
Breaking Medicine Technology:New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Seniors Can Be Heartened by New Study on Statins 2Human Urine Safe Productive Fertilizer 3130 1Human Urine Safe Productive Fertilizer 3130 2Human Urine Safe Productive Fertilizer 3130 3The Physical Therapy Profession Remains in High Demand 3127 1The Physical Therapy Profession Remains in High Demand 3127 2The Physical Therapy Profession Remains in High Demand 3127 3Webcast Alert 3A Expert Group Urges Businesses to Get Real About Weight Loss 3124 1Webcast Alert 3A Expert Group Urges Businesses to Get Real About Weight Loss 3124 2Biotech Hall of Fame Inductees Announced 1128 1Biotech Hall of Fame Inductees Announced 1128 2Biotech Hall of Fame Inductees Announced 1128 3Biotech Hall of Fame Inductees Announced 1128 4Biotech Hall of Fame Inductees Announced 1128 5Biotech Hall of Fame Inductees Announced 1128 6
(Date:11/21/2008)...Kids, parents and schools need to work together to...FRIDAY, Nov. 21 (HealthDay News) -- Behavior that ...ognized as bullying. , And as mounting research...the victim, mental-health professionals, schools, ...h new ways to combat this threatening behavior. ,...
(Date:11/21/2008)..., TALLAHASSEE, Fla. -- A Florida State Universit...g Wang has discovered an important new layer of re...ead to a greater understanding of the way cancer b...cal sciences at the College of Medicine, said the ...ose cancer and could lead to the design of new dru...
(Date:11/21/2008)...HARRISBURG, Pa., Nov. 21 /PRNewswire-USNewswire/ -...a, Governor Edward G. Rendell today remembered Li...ong teacher, an important partner in public servic...ylvania. , , "As the first woman elected li...ed public servant," said Governor Rendell. "Her fa...
(Date:11/21/2008)...TUCSON, Ariz., Nov. 21 T... ) today announced that Craig A. Norris, the Compa...to the Company,s Board of,Directors. Mr. Norris,...008,resignation of Steven I. Geringer and returns...erve on any committee of the Board. , Mr. N...
Breaking Medicine News(10 mins):Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3
...an physician who addressed a Southern African Deve... was one of the key factors that was at the centre...do.com) says, "Aids is neither an infectious disea...utritional syndrome caused by the alarming worldwi...
...tration has approved GlaxoSmithKline's new drug La...hose partial seizures are inadequately controlled ...an expansion of the //already-approved indications...es, and for the generalized seizures of Lennox-Gas...
...esearch Centre in India has shown that nearly 80 p...had considerable improvement when they followed sa...as conducted// as a result of doctors discovering ...ed neuropathy and often had to undergo amputation ...
...that has been plaguing mankind is the secret of ha...een able to unravel the mystery with a simple equa...ter a study of more than 1000 people. It is based ...red on a scale of 1 to 10 and the score is out of ...
Other Medicine News:Health News:The Happiness Formula.... 2
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: